Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- Stanford University
- University of Copenhagen
- University of Washington
- University of California, Los Angeles
- University of North Carolina at Chapel Hill
- NEW YORK UNIVERSITY ABU DHABI
- SUNY University at Buffalo
- St Jude Children's Research Hospital
- Albert Einstein College of Medicine (Bronx, NY)
- CRUK Manchester Institute
- Institut Pasteur
- The University of Texas Southwestern Medical Center (UT Southwestern Medical Center)
- University of British Columbia
- University of Gothenburg
- University of Helsinki
- Yale School of Medicine - Department of Genetics
- Yale University
- <span lang="en">Max Planck Institute for Molecular Genetics</span>
- Baylor College of Medicine
- Biotech Research and Innovation Centre, The Lund Group, University of Copenhagen
- City of Hope
- Duke University
- Francis Crick Institute
- French National Institute for Health Research (INSERM)
- Heidelberg University
- Howard Hughes Medical Institute
- Indiana University
- Loyola University
- Nationwide Children's Hospital
- Rutgers University
- Takeda lab at University of Turku
- The University of South Dakota
- UNIVERSITY OF HELSINKI
- University of British Columbia - Department of Medicine
- University of California, Berkeley
- University of Illinois Chicago - Dept of Pharmacology & Regenerative Medicine
- University of Kansas Medical Center
- University of Nebraska Medical Center
- University of Newcastle
- University of Southern Denmark
- University of Southern Denmark (SDU)
- 31 more »
- « less
-
Field
-
University of California, Los Angeles | Los Angeles, California | United States | about 2 months ago
California, Los Angeles to investigate corneal stem cells and corneal diseases with an emphasis on translational application and therapeutic development. The Cornea Biology Laboratory, under the direction
-
within the Stanford University School of Medicine's Department of Radiation Oncology. The laboratory applies in vitro and in vivo experimental techniques to study normal and malignant stem cells in
-
become: effector cells, regulatory cells, or long-lived stem-like TCF1⁺ cells that sustain immunity. How DCs direct these outcomes is still poorly understood. Our lab studies human DC biology and
-
postdocs always work collaboratively together in teams towards common goals to ensure that no one is left to work alone on a project. Our labs are located in the Center for stem cell medicine ( https
-
interested in studying the role of cell-biomaterial interactions that 1) mediate differentiation of induced pluripotent stem cells into cardiovascular lineages, and 2) biomaterials that mediate
-
treatment of some leukaemias, but current therapies remain expensive, complex to manufacture and tailored to individual patients. Differentiation of human pluripotent stem cells (PSCs) offers a promising
-
post-mortem brain samples and stem cell derived brain cells from patients with Parkinson’s Disease in order to identify lipid changes associated with the disease pathology. Information on the
-
Yale School of Medicine - Department of Genetics | New Haven, Connecticut | United States | 14 days ago
, uterus/embryo), mammary gland, brain, bone marrow, skin or tumours. No prior lung experience is required. We study how stem cells change identity after injury and how this plasticity can lead to
-
. Our group synergizes the expertise of clinicians, bioengineers, and molecular biologists in a dynamic research environment to produce clinically-viable biomaterials. Experience with stem cells for
-
seeking a postdoctoral fellow to study the cell fate decision mechanisms in hematopoietic stem and multipotent progenitor cells using primary mouse and human bone marrow cells and patient samples. We